Načítá se...
Favipiravir use for SARS CoV-2 infection
INTRODUCTION: The pandemic of SARS CoV-2 has required urgent medical treatments for numerous patients. As no specific antiviral agents were available, different off-the-shelf alternatives have been explored. OBJECTIVE: Here, we review the rationale behind the use of Favipiravir, and report of the sp...
Uloženo v:
| Vydáno v: | Pharmacol Rep |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590246/ https://ncbi.nlm.nih.gov/pubmed/33108587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00175-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|